Fugazi Research labeled the stock of Stablecoin Development Corporation (ticker: SDEV) "uninvestable at any price above zero" in a report released October 5, 2026, arguing that the company is effectively a SKY token treasury with no operating business.

The short-focused research firm said SDEV held approximately 2.32 billion SKY tokens as of October 2, 2026, equal to about 10% of the token's total supply. Fugazi put the fair value of those holdings at roughly $180 million as of September 30, 2026, a jump from $119.2 million at the end of June 2026. The $60.8 million quarter-over-quarter paper gain came entirely from mark-to-market appreciation of a single token position.

What does the company actually do?

According to Fugazi, little beyond staking. SDEV recorded $2.2 million in staking rewards from its SKY position in Q2 2026, with no significant operating revenue elsewhere.

"A company with 'stablecoin' in its name has no stablecoin infrastructure and no operating business," the report said. "What it mostly has is a very large pile of SKY tokens."

The concentration cuts both ways on liquidity. A holder of roughly 10% of supply would struggle to liquidate without depressing the market, which Fugazi flagged as a structural concern for any prospective exit.

How did a pharma company become a SKY vault?

SDEV did not begin life as a crypto vehicle. The company was previously NovaBay Pharmaceuticals before a rebrand that moved it onto NYSE American under the SDEV ticker in April 2026. The crypto pivot was capitalized through a $134 million private placement in January 2026, of which only $25 million came in as cash. SDEV used the proceeds to acquire roughly 943.6 million SKY tokens and $51 million in stablecoins.

Fugazi's report zeroed in on who supplied those assets. The CEO of an SDEV-linked fund contributed 74% of the tokens, which the firm described as a conflict-of-interest concern tied to the placement. Overall ownership concentration and additional conflict-of-interest questions formed the rest of Fugazi's governance case.

What dilution and trading risks did the report flag?

Two items stood out:

• A pending S-3 registration could permit the resale of 212.9 million shares, roughly four times the current outstanding count.
• SDEV's own disclosures warn that wash trading may be inflating reported trading volumes, a concern Fugazi identified as a red flag.

What is at stake for existing holders?

For shareholders, the report bundles concentration risk in a single illiquid token, dilution risk from the pending S-3, governance concerns from the placement, and questions about the authenticity of reported trading volume into a single sell case.

The SKY exposure cuts both ways. The rise in fair value from $119.2 million in June to $180 million in September illustrates how quickly the balance sheet can swell when the token rallies. With no meaningful operating revenue, the company has little cushion if SKY falls, and quarterly staking rewards of $2.2 million would not offset a material drawdown.

What is the next catalyst?

The next milestones are procedural and market-driven. The S-3 registration must become effective before new shares can trade, and SDEV has not yet publicly responded to the report. SKY's spot price over the coming weeks will determine whether the $180 million mark-to-market holds or compresses.